Filing Flows

Filing Flows › Cocrystal Pharma (COCP) › Who owns the stock

Who owns Cocrystal Pharma (COCP) stock

25 funds reported Cocrystal Pharma (COCP) shares in their latest 13F filings, worth $1.4M in all. The largest holder is Vanguard Capital Management LLC ($376K). Last quarter 8 funds added to their stakes and 12 cut them.

Largest holders of COCP (13F)Largest holders of COCP (13F)Vanguard Capital Management LLC$376KVanguard Group$258KRenaissance Technologies LLC$189KTwo Sigma Investments, LP$184KGeode Capital Management, LLC$80KBlackRock$77KCitadel Advisors LLC$47KNeuberger Berman Group LLC$33KXTX Topco$31KJane Street Group, LLC$27K

Largest holders (13F)

FundSharesValueChangeQuarter
Vanguard Capital Management LLC358,228$376Kincrease2026-06-30
Vanguard Group263,987$258Kdecrease2025-12-31
Renaissance Technologies LLC179,628$189Kincrease2026-06-30
Two Sigma Investments, LP175,379$184Knew2026-06-30
Geode Capital Management, LLC76,208$80Kdecrease2026-06-30
BlackRock73,746$77Kunchanged2026-06-30
Citadel Advisors LLC45,118$47Knew2026-06-30
Neuberger Berman Group LLC31,886$33Kunchanged2026-06-30
XTX Topco29,342$31Kdecrease2026-06-30
Jane Street Group, LLC25,761$27Kincrease2026-06-30
Vanguard Fiduciary Trust24,016$25Kunchanged2026-06-30
State Street20,543$22Kunchanged2026-06-30
Parallel Advisors, LLC12,569$13Kunchanged2026-06-30
Northern Trust11,921$13Kunchanged2026-06-30
Ground Swell Capital, LLC10,752$11Knew2026-06-30

Cocrystal Pharma's latest quarter

Cocrystal Pharma, Q2 2026: revenue $105K, net loss $3.2M, operating cash flow −$2.5M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most COCP stock?

By the latest 13F filings: Vanguard Capital Management LLC ($376K); Vanguard Group ($258K); Renaissance Technologies LLC ($189K); Two Sigma Investments, LP ($184K); Geode Capital Management, LLC ($80K).

What is the short interest in COCP?

179,193 shares were sold short at the 2026-10-15 settlement, 2.25% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.